SkinBioTherapeutics plc (AIM:SBTX)

SkinBioTherapeutics Revenue

SkinBioTherapeutics had revenue of 1.58M GBP in the half year ending December 31, 2024, with 1,947.84% growth. This brings the company's revenue in the last twelve months to 2.68M, up 1,557.07% year-over-year. In the fiscal year ending June 30, 2024, SkinBioTherapeutics had annual revenue of 1.21M with 815.26% growth.

• Revenue (ttm): 2.68M
• Revenue Growth: +1,557.07%
• P/S Ratio: 16.18
• Revenue / Employee: 178.57K
• Employees: 15
• Market Cap: 43.35M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2024	1.21M	1.08M	815.26%
Jun 30, 2023	132.06K	57.30K	76.64%
Jun 30, 2022	74.76K	-	-
Jun 30, 2021	-	-	-
Jun 30, 2020	-	-	-